← All AI Engineer talks

AI Engineer World's Fair 2026

Why Your Enterprise Tech Stack Isn't Ready for AI Agents - And What to Build Instead

About this talk

Christopher Lovejoy of Anthropic and Saul Howard of Anterior explain why successful healthcare AI-agent proofs of concept encounter production barriers around enterprise integrations, compliance-grade audit trails, protected health information, access controls, customer-controlled infrastructure, and clinician escalation. They describe the application, control, and data planes involved in deployment and advocate infrastructure that supports both human and model agents with consistent context and oversight.

Chapters

  1. 0:00Speaker introductions and healthcare-agent deployment challenges
  2. 1:39Enterprise proofs of concept and the application, control, and data planes
  3. 3:14Production requirements: oversight, integrations, and compliance-grade audit trails
  4. 8:46Protected health information, role-based access, and customer-controlled environments
  5. 14:18Shared operational context for human and LLM agents

Talk transcript

  1. 0:00

    [upbeat music] Hello, everybody.

  2. 0:16

    My name's Christopher Lovejoy, and I'm a member of technical staff at Anthropic. Uh, and I work as a forward-deployed engineer, so I embed within enterprise organizations and help them get value from using AI agents.

  3. 0:27

    And I previously worked at Anterior with Saul.

  4. 0:31

    Hi, everybody. I'm Saul. I'm VP of engineering at Anterior. We're a New York-based company selling AI, uh, agentic AI to US health insurance companies. Um,

  5. 0:45

    Chris and I have spent a lot of time building in enterprise and, uh, in healthcare enterprises particularly. And, uh, healthcare is a very challenging place to develop and deploy AI.

  6. 0:58

    Uh, healthcare is so challenging because of the requirements around, uh, process and, uh, compliance, the regulatory, uh, requirements that, that, that are so important. Also, because of the, uh, direct real impact that your work has on people's lives, which is, of course, also what makes it so rewarding.

  7. 1:21

    Um, I think a lot of the learnings you can take from working in enterprise for healthcare, you can take to enterprise in other regulated industries, like finance, defense, government work, anywhere where process is so important and has to be followed.

  8. 1:39

    And in this talk, we're gonna talk about, um, some of the learnings that we've had, and specifically we're gonna talk about why enterprise tech stacks aren't ready for AI agents, and some of the primitives that we've built, uh, in the past in order to unlock them.

  9. 1:51

    And to make this concrete, let's start by considering a scenario that might be familiar to many of you, which is the enterprise proof of, proof of concept, the enterprise POC.

  10. 2:00

    And let's say we have identified a customer that we want to serve, and we've identified a priority use case with them. So obviously, we're on the healthcare track here.

  11. 2:09

    Let's consider a, um, a large health system and a use case that is some sort of administrative healthcare workflow. So you work with them, you scope out a POC, you define the metrics that you are gonna care about and you're gonna benchmar-benchmark yourselves on.

  12. 2:24

    Um, you allocate two engineers, you spend four weeks building it, and, um, the actual build-out might look a little bit something like this.

  13. 2:32

    An enterprise stack is very complicated. It's much, much more than we're showing here. But generally, you can have an application layer, a control plane layer, the data plane. You-- For your POC, you're going to need some access to the model provider as well.

  14. 2:48

    And your POC is gonna need access a-to data across all of these different planes. It may be some in the data lake, some directly from the application layer, for example.

  15. 2:57

    And so you're going to deploy it something like this. It's going to connect to all these different places. There's gonna be some offline data pulling. There's gonna be some-- maybe some online.

  16. 3:08

    Generally, you'll get access to the data and push towards the results.

  17. 3:14

    And so things go well. You, you get great results. The, the AI performs, you know, as you expected. You, you hit the performance metrics. Um, you know, it's fast, it's relatively cheap, and you hold a meeting, you present this to the relevant stakeholders, and everyone seems pretty happy.

  18. 3:27

    Um, so, you know, your chief of finance, um, in the, in the company is very excited and wants to understand what's gonna be the impact on the budget for next year.

  19. 3:35

    Uh, your chief medical officer is excited to tell his, his colleagues, you know, how accurate his AI is. Um, and the head of sales asks, "Okay, when can we put 'Powered by AI'?

  20. 3:44

    When can we put that on the websites?" Um, but the problem is that everyone here is assuming that the, the hard part is done, that the AI was, was the challenging part.

  21. 3:51

    But actually, as we know, often getting things into production is really where the challenge lies. Um, and to get a bit more specific on what that challenge looks like, um, you hold a meeting the next day.

  22. 4:01

    You bring in the relevant stakeholders to discuss productionizing this proof of concept application. And somebody raises their hand and says, "Um, can I see the, the audit trail for this?

  23. 4:11

    Like, for us, for compliance, it's critical that we can see every step, every action that the agent takes, every piece of data that it accesses. Can, can you give that to me?"

  24. 4:19

    And you realize that actually, you know, with the way things have been implemented in the initial POC, without these, um, kind of true integrations, that actually that's gonna be quite challenging.

  25. 4:28

    And then somebody else, um, pops up with some other questions. So somebody asks, "Okay, well, actually, how is data-- sensitive data being handled here? Um, how is that being passed to the agents?

  26. 4:35

    You know, we have a very strict boundary around where our data can go and where it can't go. Um, is this, is this respecting that? How does that look?"

  27. 4:42

    And then your chief medical officer says, "Okay, and who's approving the decisions here? Because we know in certain scenarios we have to escalate to a clinician who will then, uh, you know, approve or, or, or, or not agree with what the agent is saying.

  28. 4:53

    Um, so how does that happen? Like, what's the mechanism for that?" And over the course of the meetings, you know, you can imagine you get more and more questions.

  29. 4:59

    So can untrusted data manipulate the model? How do we know that the agent continues to perform well? How do we deal with integrations? How do we connect to Epic, to Salesforce, to the other kind of applications that we care about?

  30. 5:09

    And for the purposes of this talk, we're gonna focus on these four, the highlighted ones. For the other two, feel free to come and chat to me and Saul about these later.

  31. 5:16

    We're very happy to talk. But, um, just in the interest of time, we'll stay focused. And let's start with, uh, this one about the audit trail.

  32. 5:23

    So this is a question you're guaranteed to get from the security team. They're going to want to see an audit trail. And for programmers, an audit trail sounds very like a typical developer log that you might have in Datadog.

  33. 5:37

    Surely, it's, it's, it's a similar kind of thing. But for security frameworks th-that exist in the real enterprise world, like SOC 2, HITRUST, HIPAA, an audit trail is, is a bit more than that.

  34. 5:50

    It, it has to contain a complete record of absolutely every action that the agent took. It has to contain all of the places where the agent accessed data, all of the authorization by which the agent did something.

  35. 6:04

    It's, it's this complete record i-in a much more fundamental way. And, uh, you, one way of thinking about it is in a legal sense. It... Say our agent's decisions came up in a court of law, could we show a justifiable chain of evidence for why the particular actions were taken by a decision?

  36. 6:25

    And that's something that could easily happen within the healthcare context, for example.

  37. 6:29

    When I think about architecting systems like this, I think often about what do I want to make easy? What are... B- When I'm choosing my constraints, I'm saying, "Okay, these are the things I want my system to be easy," and let that drive the trade-offs that, that I'm going to make.

  38. 6:47

    And a particular pattern that, uh, uh, is used in lots of different industries, for example, in finance, is a transaction log, an immutable record of events that store all of the transactions that happen throughout the system.

  39. 7:05

    And this is append-only timestamp log. It's complete, so this is your source of truth for all of the data of the system, and it's unified. So there is only one source of truth across all of the different agents that you might have running in parallel, for example.

  40. 7:21

    And architecting this way, the making this trade-off, uh, means that auditability becomes trivial. It falls out of your data storage paradigm that you've chosen. It's sort of... It's impossible not to be able to roll back time and, and see exactly the state of the system at a pa- a particular point in time, and be able to, uh,

  41. 7:40

    provide that as an audit trail for what happened, uh, uh, at each point in time. And of course, these are trade-offs. So wh- what's the trade-off you're making here?

  42. 7:51

    I think we could say that for, uh, this kind of event logging, or sometimes called event sourcing pattern, writes become very easy, so you just drop an event. Reads become more difficult because you have to, uh, read through all of the events in order to reconstruct a view of what happened, and there are patterns like caching and

  43. 8:09

    snapshots that you can bring to, to, to make that, that simpler, but there always is more effort there. Although, I have seen in, in the healthcare context that actually you're going to want different interpretations of the raw data that your agents recorded after the fact.

  44. 8:26

    So for example, it might be that, uh, more events happened, and that changes the interpretation of the healthcare journey, and you want a different view of the s- the source of truth at that particular time.

  45. 8:38

    And this pattern makes that easy because, uh, all of your views of the data are ephemeral computed projections of the event log.

  46. 8:46

    Um, okay. Next. The compliance officer comes and is asking, "How is the sensitive data passed around the system? What's the life cycle of data within our system?" And within a healthcare context, as we all know, data means a lot.

  47. 9:04

    It's PHI, protected or personal health information. It's, uh, has legal restrictions around it. Not just HIPAA, but other legal restrictions about the use of people's data. You cannot have your agent, just as you cannot have humans, accessing and reading and utilizing healthcare data that they don't absolutely have a necessity to use at that, at that point in

  48. 9:25

    time for that particular, uh, journey. And so, uh, again, architecturally, when I think about how am I storing data within a particular system, I would like to think what is the shape of the data?

  49. 9:37

    What kind of characteristics does the data have? For healthcare data, that might be that it's very complicated. It doesn't follow strict hierarchical, um, relationships. It's, uh, sometimes unstructured, and it's sometimes structured.

  50. 9:55

    It could be very large. For example, healthcare data, one piece of healthcare data can easily be over a megabyte in size or, or much more than that. Uh, it has strict access controls, as we've been saying.

  51. 10:06

    The RBAC comes into play, like, uh, both for humans and m- and then for agents downstream of that. Uh, it may even be we... I've seen customers where they're not willing to have their healthcare data leave their own environment, leave their on-prem VPC, for example.

  52. 10:21

    So we have tangential access to their, to their data. And so an architectural paradigm I might go to is object storage. Schema-driven object storage I think is a good fit for this.

  53. 10:33

    It's m- matches well with the choice of using event logging because you can separate the two. So the events we talked about as the record of what the agent is doing at any particular time only contain references to the schema-driven blobs that are the storage of the actual healthcare data itself.

  54. 10:53

    And, uh, it's important therefore that the healthcare data is stored immutably, again, so that you can always go back in time and reconstruct what data w- the agent had access to at that particular point in time.

  55. 11:04

    This separation of events for what happened and object storage for the data that was used at that particular point in time

  56. 11:14

    has actually some, some very useful benefits. For example, with a system like this, it's possible for developers to go back and debug and have observability over what happened, what particular steps the agent took, why it did that, and, and retrace the agent's steps without having access to the personal health information itself.

  57. 11:37

    Although, because of the schema-driven, they can see the shape of that data, they, they can't and, to be honest, often won't be able to be given access to that healthcare data.

  58. 11:46

    So you can separate out observability and orchestration and instrumentation from the healthcare data itself. This then has another benefit, which is zero trust.

  59. 11:57

    It, it... The object storage becomes a place where you can apply zero trust principles. Your agents can bear tokens and use those tokens to access the data at the point of use and not allow data to f- flow around the system a- as it likes.

  60. 12:15

    This then leads into a mitigation for, uh, prompt injection for the lethal trifecta. The, the way I think about the lethal trifecta is can I solve for the constraint if I have an agent at point A with access to this data, is it possible within my architecture for the agent to be also accessing data over here?

  61. 12:36

    And zero trust principles, tokens, uh, beared by the agents, and object storage segregated from the, uh, event stream that has your orchestration logic gives you a place to be able to solve for that constraint.

  62. 12:48

    It won't be possible for the agent to access data within the same process that, that you've given it the, the previous data.

  63. 12:58

    Okay, so then it comes to how do you handle escalation? And in many scenarios, you will want to be able to escalate the decision that an agent makes or an action that an agent makes to a human.

  64. 13:10

    But one of the challenges here is that this is quite dynamic, so you don't know in advance when exactly perhaps the agent's going to escalate. It could be that you're asking the AI to escalate when it's not sure.

  65. 13:20

    Um, it could be that you define some sort of rules in your system, maybe in a medical context, the treatments going above a certain threshold means that it needs to be escalated, uh, for an approval. [sniffs]

  66. 13:30

    But this makes it very challenging, um, because of this, this inability to predict. And a second challenge is also that humans and LLMs ultimately process context differently. You know, LLMs will have no problem if you give them massive, massive amounts of text, but humans, um, that's not the case.

  67. 13:45

    So what we've seen is that one pattern that can work very well here is if in your platform you enforce kind of a wider definition of agent which encompasses both LLMs and humans, then you can make it such that any action that can be taken by an LLM could also be taken by a human.

  68. 14:03

    And this is helpful because at any point in the kind of chain of actions that your agent is taking, it can escalate to a human, the human could perform that action, and then any step downstream doesn't care about whether it was a human or an LLM that did those actions upstream. [lip smack]

  69. 14:18

    Um, and on the second point around the context, what this also, uh, makes much easier is that you can define methods that take the context which has some kind of shared definition of context, which is irrespective of whether it's a, a human or an LLM that's gonna be accessing it.

  70. 14:35

    And you can take those methods to then map into something that's agent-friendly, like a prompt, or into something that's more human-friendly, for example, a UI.

  71. 14:47

    And then on this fourth and final question that we're gonna talk about, um, evals.

  72. 14:53

    Obviously, you know, we hear a lot about evals. We know that evals can be very helpful, that often they drive decision-making about the types of model you want to use, the type of approach you might want to use, um, within your product.

  73. 15:03

    But we also know that evals can be pretty hard, and there's various factors here. We know that LLMs are not deterministic, so it can be quite tricky to pin down the precise change that led to some sort of change in output. [lip smack]

  74. 15:15

    Um, we also know that the data that you might put in an offline data set might not necessarily represent production data, and it could be that, um, maybe you, you sampled from data, but actually, that sample isn't truly representative.

  75. 15:28

    And then you also have drift of data, um, over time, so maybe your offline data set is now out of date.

  76. 15:36

    And what we found is that these three primitives that we've described, described so far in the talk actually give you effective privacy preserving evals almost as a byproduct, um, without needing to kind of bolt something onto the side of y- of your, um, architecture.

  77. 15:52

    So to make that more concrete, so the immutable ledger, what this means is that you can replay your actions. So you can go back to any particular time, you know, in this sort of sequence of events.

  78. 16:01

    You can see the complete state of the system at that point in time. And if you wanted to, you could then make very specific tweaks. So you could tweak a prompt.

  79. 16:08

    You could tweak a model. You could tweak the code. And you can see the exact direct impact of that because you have all of that context.

  80. 16:16

    Secondly, you have this human-agent equivalency, which means that for any task, you could get both the agent, the LLM agent, and the human to perform it, and your difference is your eval.

  81. 16:28

    That gives you the eval scores. And then finally, what the object storage enab- enables you to do is to actually run these evals on production data, um, including inside your customer's environment without actually ever exposing that data.

  82. 16:40

    And you can get your eval results without the sensitive data ever needing to come to where your agent's performing the work.

  83. 16:48

    Right. So we've gone through four architectural principles that we found useful for building in healthcare and more generally in regulated environments for enterprise. The immutable ledger of actions, the orchestration-adjacent object storage, the human-agent equivalency, and the way that with these three principles, evals can emerge as a first-class property of the system

  84. 17:13

    rather than as something y- you attach onto the side. I think one of the metas here is that I like to think about architecture as taking your constraints very seriously and thinking about what you want to be simple within the system and then choosing the trade-offs for that.

  85. 17:31

    And of course, alongside that, some things will become hard, but it's the things that are simple that are most important to you. And that there are patterns that already exist across enterprises that solve for a lot of these things.

  86. 17:42

    And sure, with AI, we need to combine them in new, sometimes radical ways and bring in other way-- uh, other pieces. But there are patterns that have worked very well within finance, within defense, within big tech that, that could be applied to this kind of system architecture.

  87. 17:56

    And I'd say the takeaway is that where I've seen it go wrong is taking that initial POC, that, um, that point solution that showed so much promise and that, that sh- showed the high accuracy, for example, and then trying to build up from it, strapping on the enterprise requirements as you come across them.

  88. 18:16

    Okay, we need evals. We need, uh, security. We need auditability. And bolting these on as additions to the, the, the foundations of the POC. You end up with something very brittle, something very hard to, uh, uh, externalize and to generalize across different use cases.

  89. 18:32

    But where I've seen it go well is if you take the constraints of a production-ready, scaled enterprise, uh, system seriously from the beginning and treat those as the architectural principles that you're going to build everything upon and then build back up towards that POC accuracy using your new primitives.

  90. 18:53

    Thank you for your attention.

  91. 18:54

    Thank you. [audience applauding] [outro music]